Evaluation of the current situation and possibilities in the management of obesity in Slovakia

Czech version

Authors: Ubomíra Fábryová
Authors‘ workplace: MetabolKLINIK s. r. o., Ambulancia pre diabetológiu, poruchy látkovej premeny a výživy, MED PED centrum, Bratislava ¹; Biomedicínske centrum Slovenskej Akadémie Vied, Bratislava ²; Vysoká škola zdravotníctva a sociálnej práce sv. Alžbety, Inštitút prevencie a intervencie, Bratislava ³
Published in: Diab Obez 2023; 23(45): 22-28
Category:

Overview

Obesity is recognized as a chronic, recurrent and progressive metabolic disease with the accumulation of body (visceral, ectopic) fat with a high prevalence worldwide, affecting not only adults, but also children and adolescents. Obesity is insufficiently treated in clinical practice, the reason being that in many countries obesity is not considered as a chronic lifelong disease, thus denying patients the right to real help. Overweight and obesity are not avoided even in Slovakia, and we are among the nations with a high prevalence of obesity. It significantly increases the cardiometabolic load, especially the risk of developing type 2 diabetes, arterial hypertension, lipid metabolism disorders, metabolic syndrome, myocardial infarction, stroke, heart failure, obstructive sleep apnea syndrome, specific types of oncological diseases, metabolic associated fatty liver disease, gastroesophageal reflux, osteoarthritis and arthritis, polycystic ovarial syndrome, infertility, depressive syndromes, neurodegenerative diseases, etc. Obesity affects the quality and length of life of people living with obesity. In the complex management of obesity, we are ultimately concerned with the reduction of cardiovascular risk factors, domácardiovascular events, as well as a decrease in both cardiovascular and overall mortality, and an improvement in the quality and length of life. The article evaluates the current situation in the management of individuals with overweight and obesity in Slovakia. We still have a lot of work to do to raise awareness of obesity as a chronic disease with numerous serious complications, among the general public and among health professionals. Our goal is to create awareness of obesity-related issues at the legislative level; prepare suitable conditions for increasing the involvement of medical and non-medical professions in the obesity management process; to evaluate the benefits of all long-term therapeutic strategies for weight loss and maintenance in terms of health risks, quality of life and cost-effectiveness.

Keywords:

Education – bariatric metabolic surgery – care of patients with obesity – comprehensive management of obesity – pharmacotherapy with antiobesity drugs – prevalence of overweight and obesity – standard diagnostic and therapeutic procedures

Sources

1. Fábryová Ľ et al. Štandardné diagnostické a terapeutické postupy v manažmente obézneho jedinca. MZSR 2021. Slovenská obezitologická asociácia 2021. ISBN 978–80–570–3807–8. Dostupné z WWW: <https://www.health.gov.sk/?Standardne-Postupy-V-Zdravotnictve>.

2. Fábryová Ľ. Obezita a jej manažment. In: Martinka E (ed) et al. 2021 Konsenzuálne odporúčania Slovenskej diabetologickej asociácie (SDiA) a Slovenskej diabetologickej spoločnosti (SDS) pre liečbu diabetes mellitus 2. typu. Forum Diab 2021; 10(Suppl 2): 180–201.

3. World Obesity Federation. 2021 COVID-19 and Obesity: The 2021 Atlas. Dostupné z WWW: <https://www.worldobesity.org/>.

4. Avdičová M, Francisciová KM, Ďateľová M. Monitorovanie rizikových faktorov chronických chorôb v SR. Banská Bystrica: RÚVZ so sídlom v Banskej Bystrici za podpory WHO – regionálnej úradovne v Kodani, 2012. ISBN 978–80–71096–0–8.

5. [OECD]. Overweight and obesity among adults. In: Health at a Glance 2021. OECD Indicators. OECD Publishing: Paris 2021. Dostupné z WWW: <https://www.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-2021_0f705cf8-en>.

6. IQVIA™. Obesity Insights – Market Research Study. 2022. Dostupné z WWW: <https://www.iqvia.com/insights#>.

7. Tichá Ľ, Regecová V, Šebeková K et al. Prevalence of overweight/obesity among 7-year-old children—WHO Childhood Obesity Surveillance Initiative in Slovakia, trends and differences between selected European countries. Eur J Pediatr 2018; 177(6): 945–953. Dostupné z DOI: <http://dx.doi.org/10.1007/s00431–018–3137–7>.

8. Vitáriušová E, Kostalova L, Pribilincova Z et al. 2010. Problems of metabolic syndrome diagnostics in children. Endocr Regul 2010; 44(3): 115–120.

9. Madarasova Geckova A, Bakalár P, Baška T et al. HBSC – Slovensko – 2017/2018 Národná správa o zdraví a so zdravím súvisiacom správaní 11, 13 a 15-ročných školákov na základe prieskumu uskutočneného v roku 2017/2018 v rámci medzinárodného projektu „Health Behaviour in School-aged Children“. (HBSC). Úrad verejného zdravotníctva Slovenskej republiky: Bratislava 2019. ISBN: 978–80–7159–242–6.

10. OECD/European Observatory on Health Systems and Policies. Slovak Republic: Country Health Profile 2021. State of Health in the EU. OECD Publishing: Paris 2021. Dostupné z DOI: <https://doi.org/10.1787/4ba546fe-en>.

11. IHME (Institute for Health Metrics and Evaluation). Global Health Data Exchange.Global Burden of Disease Study 2019. GBD 2019. Dostupné z WWW: <https://ghdx.healthdata.org/>.

12. Kahan S, Zvenyach T. Obesity as a Disease: Current Policies and Implications for the Future. Curr Obes Rep 2016; 5(2): 291–297. Dostupné z DOI: <https://doi.org/10.1007/s13679–016–0218–7>.

13. Marko, Ľ., Fábryová, Ľ. Viera Kissová et al. Štandardný diagnostický a terapeutický postup na komplexný manažment pre chirurgickú liečbu obezity v dospelom veku. Ministerstvo zdravotníctva Slovenskej republiky: Bratislava 2021. Dostupné z WWW: <https://www.mzsr.sk/>.

14. Minárik P, Penesová A, Mináriková D et al. Odporúčania pre stravu a výživu u dospelých. Ministerstvo zdravotníctva Slovenskej republiky: Bratislava 2022. Dostupné z WWW: <https://www.mzsr.sk/>.

14. Meier T et al. GBD 2017 Diet Collaborators.Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2019; 393(10184): 1958–1972. Dostupné z DOI: <https://doi.org/10.1016/S0140–6736(19)30041–8>.

15. Golian J, Minárik P, Mináriková D. Potravinová a nutričná gramotnosť 1–3. Raabe 2022. ISBN 978–80–8140–621–8.

16. Peters S, Verhagen H. An Evaluation of the Nutri-Score System along the Reasoning for Scientific Substantiation of Health Claims in the EU – A Narrative Review. Foods 2022; 11(16): 2426. Dostupné z DOI: https://doi.org/10.3390/foods11162426

17. Tlačová správa Pro Nutri-Score Aliancie. 2021. 28. 4. 2021. Bratislava. Dostupné z WWW: <https://www.nutriscoreslovakia.sk/>.

18. European Health Public Association Statement on front-of-pack nutrition labelling in the European Union 2023. Dostupné z WWW: <https://eupha.org/repository/advocacy/2023/EUPHA%20Statement%20on%20FoPNL%20FINAL.pdf>.

19. Ukropcová B, Ukropec J, Hamar D. Odporúčania pohybovej aktivity v manažmente pacienta s obezitom a diabetom mellitom 2. typu. Preskripcia pohybovej aktivity: odporúčania pre prax. Via Pract 2020; 17(2): 11–16.

20. Fábryová Ľ. Novinky vo farmakologickej liečbe obezity/diabezity. Via Pract 2022; 19(5): 199–204.

21. Tsigos C. Vojtech Hainer, Arnaud Basdevant et al. Criteria for EASO-Collaborating Centers for Obesity Management. Obes Facts 2011; 4(4): 329–333. Dostupné z DOI: <http://dx.doi.org/10.1159/000331236>.